Origin Enterprises plc (LON:OGN – Get Free Report)’s share price reached a new 52-week high during trading on Tuesday after the company announced a dividend. The stock traded as high as GBX 3.60 ($0.05) and last traded at GBX 3.52 ($0.05), with a volume of 5500 shares. The stock had previously closed at GBX 3.45 ($0.05).
The newly announced dividend which will be paid on Friday, February 14th. Investors of record on Thursday, January 23rd will be paid a €0.14 ($0.15) dividend. This is an increase from Origin Enterprises’s previous dividend of $0.03. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a yield of 3.96%. Origin Enterprises’s dividend payout ratio is presently 3,953.49%.
Analyst Ratings Changes
Separately, Shore Capital reiterated a “buy” rating on shares of Origin Enterprises in a research note on Tuesday.
Origin Enterprises Trading Up 2.0 %
The stock has a market cap of £3.73 million, a P/E ratio of 8.19 and a beta of 0.72. The firm’s fifty day moving average price is GBX 3.20 and its two-hundred day moving average price is GBX 3.17. The company has a debt-to-equity ratio of 94.70, a current ratio of 1.42 and a quick ratio of 0.69.
About Origin Enterprises
Origin Enterprises plc provides agronomy services company in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania, Ukraine, and Latin America. It develops products and services to improve soil fertility, nutrient use efficiency, and crop productivity. The company provides integrated agronomy and on-farm services comprising agronomy advice, services, and inputs directly to arable, fruit, and vegetable growers; and seed, nutrients, crop protection products and digital tools.
Read More
- Five stocks we like better than Origin Enterprises
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Compound Interest and Why It Matters When Investing
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Basic Materials Stocks Investing
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Origin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Origin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.